210 related articles for article (PubMed ID: 30864100)
21. Steroids for PML-IRIS: a double-edged sword?
Berger JR
Neurology; 2009 Apr; 72(17):1454-5. PubMed ID: 19144930
[No Abstract] [Full Text] [Related]
22. Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.
Aly L; Yousef S; Schippling S; Jelcic I; Breiden P; Matschke J; Schulz R; Bofill-Mas S; Jones L; Demina V; Linnebank M; Ogg G; Girones R; Weber T; Sospedra M; Martin R
Brain; 2011 Sep; 134(Pt 9):2687-702. PubMed ID: 21908874
[TBL] [Abstract][Full Text] [Related]
23. Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV.
Corey S; Smith BR; Cortese ICM
Curr HIV/AIDS Rep; 2022 Dec; 19(6):580-591. PubMed ID: 36181625
[TBL] [Abstract][Full Text] [Related]
24. Effective immune restoration after immunosuppressant discontinuation in a lupus patient presenting progressive multifocal leukoencephalopathy.
Lefèvre G; Queyrel V; Maurage CA; Laurent C; Launay D; Lacour A; Charlanne H; Morell-Dubois S; Lambert M; Maillard H; Vermersch P; Hachulla E; Hatron PY
J Neurol Sci; 2009 Dec; 287(1-2):246-9. PubMed ID: 19815239
[TBL] [Abstract][Full Text] [Related]
25. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
26. [Progressive multifocal encephalopathy in neurological practice].
Putilina MV; Ermoshkina NY; Sigitov IS; Sidelnikova LV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):95-105. PubMed ID: 29376991
[TBL] [Abstract][Full Text] [Related]
27. Progressive multifocal leukoencephalopathy therapy.
Clifford DB
J Neurovirol; 2015 Dec; 21(6):632-6. PubMed ID: 25227934
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of progressive multifocal leukoencephalopathy: a practical approach.
Bartsch T; Rempe T; Leypoldt F; Riedel C; Jansen O; Berg D; Deuschl G
Eur J Neurol; 2019 Apr; 26(4):566-e41. PubMed ID: 30629326
[TBL] [Abstract][Full Text] [Related]
29. Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone.
Focosi D; Fazzi R; Montanaro D; Emdin M; Petrini M
Antiviral Res; 2007 May; 74(2):156-8. PubMed ID: 17140673
[TBL] [Abstract][Full Text] [Related]
30. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
31. Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
Loignon M; Toma E
Expert Rev Anti Infect Ther; 2016; 14(2):177-91. PubMed ID: 26655489
[TBL] [Abstract][Full Text] [Related]
32. Progressive multifocal leukoencephalopathy.
Weissert R
J Neuroimmunol; 2011 Feb; 231(1-2):73-7. PubMed ID: 20937530
[TBL] [Abstract][Full Text] [Related]
33. Immune reconstitution inflammatory syndrome in a patient with progressive multifocal leukoencephalopathy.
Shahani L; Shah M; Tavakoli-Tabasi S
BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26063110
[TBL] [Abstract][Full Text] [Related]
34. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
[TBL] [Abstract][Full Text] [Related]
35. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
[TBL] [Abstract][Full Text] [Related]
36. Slowly progressive fatal PML-IRIS following antiretroviral initiation at CD4+ nadir of 350 cells/mm
Sandhu MR; Rutledge R; Grant M; Mahajan A; Spudich S
Int J STD AIDS; 2019 Jul; 30(8):810-813. PubMed ID: 31046614
[No Abstract] [Full Text] [Related]
37. Increased program cell death-1 expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy.
Tan CS; Bord E; Broge TA; Glotzbecker B; Mills H; Gheuens S; Rosenblatt J; Avigan D; Koralnik IJ
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):244-8. PubMed ID: 22549384
[TBL] [Abstract][Full Text] [Related]
38. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy.
Venniyoor A
Saudi J Kidney Dis Transpl; 2019; 30(4):998-999. PubMed ID: 31464264
[No Abstract] [Full Text] [Related]
39. Progressive multifocal leukoencephalopathy in the context of newer therapies in hematology and review of new treatment strategies.
Diamantopoulos PT; Kalopisis K; Tsatsou A; Efthymiou A; Giannakopoulou N; Hatzidavid S; Viniou NA
Eur J Haematol; 2022 May; 108(5):359-368. PubMed ID: 35100451
[TBL] [Abstract][Full Text] [Related]
40. Progressive multifocal leukoencephalopathy secondary to hepatitis C virus infection-related T-cell lymphopenia.
Aung AK; Robinson J; Hey P; Lehmann M; Chow Y; Stark RJ; Bosco JJ
Intern Med J; 2019 Jan; 49(1):114-118. PubMed ID: 30680891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
